Kite Pharma, Inc. (NASDAQ: KITE) Shares Jump on Study Results: U.S. Daily Market Movers

Published:

Small
cap stocks making big moves on Tuesday, August 26, 2014 (as of 4 pm EST), as
reported by Sean Mason, SmallCapPower.com

Kite Pharma, Inc. (NASDAQ: KITE)
shares climbed 18% to $26.25 on volume of more than 5.6 million shares Tuesday
after the clinical-stage biopharmaceutical firm published encouraging
data from its Phase 1-2a clinical trial of patients with aggressive
non-Hodgkins lymphoma.

As well,
shares of Adept Technology, Inc. (NASDAQ: ADEP)
slid 19% to $9.01 on more than 2.1 million shares traded as the provider of
intelligent robots reported fiscal fourth quarter earnings and
revenue that fell short of Wall Street expectations.

MediciNova, Inc. (NASDAQ: MNOV),
meanwhile, said it has received FDA approval to initiate a clinical trial of
MN-166 (ibudilast) in amyotrophic lateral sclerosis (ALS), also known as Lou
Gehrig’s disease. MediciNova shares moved up 8% to $2.25 following the
announcement.

Finally, Xueda Education Group (NYSE: XUE)
shares fell 19% to $3.74 after the provider of personalized tutoring services
for primary and secondary school students in China announced Q2 earnings that
missed analysts’ expectations. 

Related articles

Recent articles